Blog Clinic Community Medical Specialty 
ABIM
JUNE 12, 2025
Visit the ABIM Blog for reports of prior meetings. Ruiz first joined the Specialty Board as a member in 2021. Expanding ABIM’s engagement with stakeholder communities such as early career physicians, specialty societies and patient-focused organizations. The following is a summary of the spring meeting.
FDA Law
JULY 17, 2024
Peter Marks at James Valentine ’s FDA Rare Disease Town Hall session at the DIA Annual Meeting last month (see Pink Sheet coverage here ), this Hub is intended to serve as the Center of Excellence that we in the rare disease community have been calling for its establishment over the last several years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ABIM
MAY 7, 2025
The rigorous, formalized blueprint review process includes several steps to gather feedback from physicians, medical specialty societies and medical educators. If you are interested in providing ABIM with feedback, consider joining the Community Insights Network to participate in panel discussions and surveys.
ABIM
JUNE 4, 2025
Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. Visit the ABIM Blog for reports of prior meetings.
ABIM
JUNE 11, 2025
Visit the ABIM Blog for reports of prior meetings. JD , whose terms on the Specialty Board end June 30, 2025. Expanding ABIM’s engagement with stakeholder communities such as early career physicians, specialty societies and patient-focused organizations. The following is a summary of the spring meeting.
Expert insights. Personalized for you.
52 
Let's personalize your content